DEFA14A ·Filed Apr 22, 2026
Proxy solicitation materials
Actionable Insight • Neutral
Monitor for any shareholder dissent on executive compensation, though this routine filing suggests business as usual.
Final — all horizons settled through T+60d
XENE ▲ +19.18% at T+60d
NEUTRAL call ✓ call won +19.18% · α vs SPY +14.17% · entry $55.41 → $66.04
T+1d
-0.31%
call -0.31% · α -1.09%
$55.24
settled 5mo ago
T+5d
+0.61%
call +0.61% · α -0.86%
$55.75
settled 5mo ago
T+20d
-1.32%
call -1.32% · α -5.95%
$54.68
settled 5mo ago
T+60d
+19.18%
call +19.18% · α +14.17%
$66.04
settled 2mo ago
Price Chart
Loading chart...
Executive Summary
Xenon Pharmaceuticals filed a definitive proxy statement for its 2025 annual meeting, proposing the re-election of eight directors, approval of executive compensation, and reappointment of its auditor. This routine filing follows a recent amendment to its equity incentive plan, indicating ongoing governance activities.
Key Facts
- Filing is a definitive proxy statement (DEFA14A) for the 2025 annual meeting
- Proposes re-election of eight directors including Dawn Svoronos, Gillian Cannon, and Justin Gover
- Seeks approval of executive compensation and reappointment of PwC as auditor
- Follows recent 8-K filing amending the equity incentive plan
Financial Impact
Routine governance filing with no immediate financial impact
governanceexecutive compensation
Risk Factors
- Potential shareholder dissent on executive compensation
- Board continuity risk if any directors are not re-elected
Market Snapshot
Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Investment Themes
Biotech & Drug Discovery
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| DEFA14A Filing (Primary) | 0001193125-26-170335 |
| Document: 0001193125-26-170335-index-headers.html | 0001193125-26-170335 |
| Document: 0001193125-26-170335-index.html | 0001193125-26-170335 |
| Document: 0001193125-26-170335.txt | 0001193125-26-170335 |
11 reports for XENE
100% Hit rate best @ T+60▲ +18.60%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Jul 2, 2026 13w ago | Press Release | $60.96 $64.19 | ▲ +5.30% | ▲ +5.71% | $38.02 (−37.63%) |
Jun 5, 2026 17w ago | 144 | $51.21 $60.54 | ▲ +18.22% | ▲ +16.59% | $38.02 (−25.76%) |
Jun 3, 2026 17w ago | 8-K | $52.99 $60.96 | ▲ +15.04% | ▲ +16.41% | $38.02 (−28.25%) |
May 7, 2026 21w ago | Press Release | $56.44 $51.73 | ▼ −8.35% | ▼ −8.37% | $38.02 (−32.64%) |
Apr 22, 2026 23w ago | DEFA14A | $55.41 $54.68 | ▼ −1.32% | ▼ −5.95% | $38.02 (−31.38%) |
Apr 19, 2026 23w ago | Press Release | $57.09 $53.71 | ▼ −5.92% | ▼ −10.12% | $38.02 (−33.40%) |
Apr 15, 2026 24w ago | Press Release | $58.88 $55.00 | ▲ +6.59% | ▲ +12.63% | $38.02 (+35.43%) |
Apr 13, 2026 24w ago | 8-K | $59.35 $55.78 | ▼ −6.02% | ▼ −12.31% | $38.02 (−35.94%) |
Apr 7, 2026 25w ago | Press Release | $57.65 $57.40 | ▲ +0.43% | ▲ +10.21% | $38.02 (+34.05%) |
Mar 13, 2026 29w ago | Insider Cluster | $55.23 $58.60 | ▼ −6.10% | ▼ −2.51% | $38.02 (+31.16%) |
Showing 10 of 11
US Market Status
Market Closed — Opens Mon (64h 9m)
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access